Previous Next

News Releases    Health & Medical

Translations: 


Health & Medical Results: 2378 item(s)
PARIS and GENEVA, June 9, 2022 /PRNewswire-AsiaNet/ -- - 11 Organisations Provide Examples, Learnings and Recommendations on How to Improve Nutrition at Work The Consumer Goods Forum (CGF) and the Global Alliance for Improved Nutrition (GAIN) ( https://www.gainhealth.org/ ), as part of the Workforc...
PETACH TIKVAH, Israel, June 8, 2022 /PRNewswire-AsiaNet/ -- Today, Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international markets, is pleased to announce the approval of KIMMTRAK(R) (tebentafusp) by Health Canada and Thera...
DUSSELDORF, Germany, June 8, 2022/PRNewswire-AsiaNet/-- LenioBio GmbH today announced it had achieved a key milestone for the company with the successful linear scaling of its cell-free protein synthesis (CFPS) platform, ALiCE(R), to an industrial scale. Through a series of breakthrough developments...
GAITHERSBURG, Md., June 7, 2022 /ASIANET-PRNewswire/ -- --Novavax COVID-19 vaccine receives positive vote from U.S. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee --If Emergency Use Authorization is granted by the FDA, the Novavax COVID-19 vaccine ...
LEIPZIG, Germany, June 8, 2022 /PRNewswire-AsiaNet/ -- The first patient has been enrolled in the FDA IDE BTK (Below-the-Knee) SELUTION4BTK clinical trial involving SELUTION SLR(TM), MedAlliance's novel sirolimus-eluting balloon, just one week after receiving IDE approval. "I am excited to ...
FLORENCE, Italy and BOSTON, June 6, 2022 /PRNewswire-AsiaNet/-- Subgroup analysis of patients with no prior chemotherapy in EMERALD: A phase 3 trial evaluating elacestrant, an investigational oral selective estrogen receptor degrader (SERD), vs. investigator’s choice of endocrine monotherapy for ER+/HER2- adva...
PETACH TIKVAH, Israel, June 6, 2022 /PRNewswire-AsiaNet/ -- Medison Pharma [http://www.medisonpharma.com/] ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international markets, announced today an exclusive multi-regional agreement with argenx ...
SUZHOU, China, June 6, 2022 /PRNewswire-AsiaNet/ -- * The National Medical Products Administration approved sugemalimab for the treatment of patients with unresectable stage III non-small cell lung cancer whose disease has not progressed following concurrent or sequential platinum-based chemoradiot...
Image Attachment
NANJING, China, June 2, 2022 /PRNewswire-AsiaNet/-- Vazyme, China's leading biotechnology company, has recently released its 2021 annual report, revealing that the company has maintained a steady and solid growth throughout the past year. The report shows that it has achieved $289 million in operat...
EAST RUTHERFORD, NJ, June 1, 2022, /PRNewswire-AsiaNet/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced the acquisition of Q1 Scientific – a leading pro...

Previous Page Page 8 of 238 Next Page ...  3  4  5  6  7  8  9  10  11  12  ... Go to page Go